Webdog
Senior Member (Voting Rights)
Though this video/article is primarily about vitamin D and colorectal cancer risk, it delves into Vitamin D's role in the gut microbiome and inflammatory/infectious disease. It covers research that will be published in 2019.
It concludes that it's time for doctors right now to consider Vitamin D supplementation for at-risk patients, and that the traditional levels are too low.
I found it interesting, as Vitamin D is one of the very few supplements that I get a clear benefit from. I was once chastised by a doctor for having a "much too high" Vitamin D3 level of just over 100 nmol/L (edit: 25(OH)), which is what Dr. Johnson is recommending here.
Vitamin D Deficiency Elevates Colorectal Cancer Risk
https://www.medscape.com/viewarticle/904115
It concludes that it's time for doctors right now to consider Vitamin D supplementation for at-risk patients, and that the traditional levels are too low.
I found it interesting, as Vitamin D is one of the very few supplements that I get a clear benefit from. I was once chastised by a doctor for having a "much too high" Vitamin D3 level of just over 100 nmol/L (edit: 25(OH)), which is what Dr. Johnson is recommending here.
Vitamin D Deficiency Elevates Colorectal Cancer Risk
https://www.medscape.com/viewarticle/904115
David A. Johnson MD said:Vitamin D affects the microbiome. There's a mechanistic role in T-cell trafficking and a significant effect as it relates to the immune function. Regarding the potential for promotion of synthesis and the bad things that upregulate cancers and inflammation, we know that vitamin D actually inhibits the response of tumor necrosis factor-alpha. There's an anti-inflammatory response with cytokine interleukin-10.
David A. Johnson MD said:The results essentially show that the more vitamin D you get, the better. However, there seemed to be a plateau effect at 100 nmol/L. It didn't mean that more was better forever; there wasn't a linear relationship. Nonetheless, it raises the bar for vitamin D supplementation in our patients.
David A. Johnson MD said:Putting It Into Practice
I've also used supplementation in patients with diverticulitis, which we know to occur more frequently in patients with lower vitamin D. When you get into some of the anti-inflammatory effects of vitamin D on proliferation, differentiation, barrier function, and immune response, it makes sense to start looking at this in inflammatory/infectious disease as well.
In summary, vitamin D is really essential in homeostasis and signaling. It affects the microbiome and has a direct effect on host intestinal inflammation. We do know that this certainly plays out in inflammatory bowel disease.
David A. Johnson MD said:It remains to be determined whether supplementation makes a big difference as far as clinical outcomes. However, to me, there's clear evidence that it modulates inflammation, maintains epithelial integrity, and reduces intestinal proliferation. In my practice, it's ready for primetime. I think it should be in yours as well.
Start to look at supplementation; perhaps measure the patient's vitamin D levels, and monitor and target it in patients—particularly those at risk. I do think this represents translational, bench-to-bedside research that is ready for primetime now.
Last edited: